For the first time, we report 30 and 25 autoantibodies that were significantly lower in ACPA+ RA and ACPA− RA, respectively, compared with controls (Fig. 3 and Supplementary Table 6). The gene discussed is PRTN3; the disease is rheumatoid arthritis.